Projekt · Dnr 2019-05674 · Källa: Vinnova

Nytt vaccin mot mastit hos nötkreatur orsakad av Staphylococcus aureus

Koordinator
Intervacc AB
Projekttid
2020-05-01 till 2021-10-31 (avslutat)
Beviljat bidrag
1 943 296 SEK
Diarienummer
2019-05674

Beskrivning

Mastitis is one of the most important diseases in dairy cattle causing significant losses to the dairy industry. Staphylococcus aureus is the causative agent of around 25% of contagious mastitis cases in Europe, accounting for over 2.6 million cases at an annual cost of 597M€. This project aimed to develop and test the safety and immunogenicity of a new multicomponent recombinant fusion protein vaccine in heifers with which to address this unmet medical need. Four recombinant fusion proteins comprised of a total of 43 different fragments of 20 S. aureus proteins were generated, purified and formulated as a vaccine to target multiple virulence pathways and account for strain variation. Pregnant heifers were vaccinated on three occasions via intramuscular injection and blood samples were collected to measure the immune responses that were generated. Vaccination was well tolerated and induced antibody responses to 18 of the 20 S. aureus proteins in the vaccine.

Öppna hos Vinnova

Hittar Vinnova inte sidan? Sök på diarienumret hos Vinnova.

Liknande

  1. Nytt effektivt Stafylokockus aureus vaccin mot Mastit som ersätter antibiotikaanvändning

    SAVACC AB · 2019-05-30 · 890 000 SEK · Projekt

    SLU är ett universitet och fordrar publisering. Ett Staphylococcus aureus (SA) vaccin har framställt som är innovativt både vad gäller antigen och adjuvans. Det har framkallat potenta antikrops nivåer me blod serum och mjölk. Vi tror SAvaccinet skall framakalla skudseffekt The test vaccine Chrivacc …

  2. Effektivt besättningseget vaccin mot Staphylococcus aureus mastit för mjölkkor

    SAVACC AB · 2017-10-20 · 300 000 SEK · Projekt

    Syftet med projektet är att skapa en process för tillverkning av autogena dvs besättningsegna SA vaccin med god gärna excellent effekt. Alla nödvändiga delar i processen för att skapa ett vaccin från diagnostik av mastit till vaccinering är etablerad och skall nu prövas i praktiken. Syftet på kort s…

  3. E!12402, VASIP, Vaccine Against Streptococcus suis Infections in Pigs, Intervacc AB

    Intervacc AB · 2018-11-01 · 5 000 000 SEK · Projekt

    Streptococcus suis is an important endemic pathogen of piglets, causing meningitis, arthritis, endocarditis and septicaemia with mortality rates of between 1% and 20%. Piglets are most susceptible to infection in the period immediately post-weaning leading to treatment with antibiotics and significa…

  4. E!4692, VASIP, Intervacc

    Intervacc AB · 2024-04-01 · 5 000 000 SEK · Projekt

    Streptococcus suis (S. suis) is an important endemic pathogen generating significant economic losses in the pig industry worldwide. Piglets develop disease post-weaning at between 4 and 10 weeks of age as the levels of maternal antibodies, which were passively acquired via the consumption of colostr…

  5. Implementering av en ontologi för syndromklassificering av djurhälsodata

    STATENS VETERINÄRMEDICINSKA ANSTALT · 2017-11-01 · 738 176 SEK · Projekt

    This project aimed to implement an ontology of health surveillance into the framework of animal disease surveillance at the Swedish National Veterinary Institute (SVA). We were able to achieve this goal, while expanding the health data coverage to include also data from food safety and human disease…